iohexol and butyryl-n-trihexylcitrate

iohexol has been researched along with butyryl-n-trihexylcitrate in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bayer, G; Byrne, RA; Hartwig, S; Joner, M; Joost, A; Radke, PW; Steigerwald, K; Wittchow, E1
Almalla, M; Burgmaier, M; Reith, S; Schröder, J; Vogt, F1

Other Studies

2 other study(ies) available for iohexol and butyryl-n-trihexylcitrate

ArticleYear
Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipients.
    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2011, Oct-30, Volume: 7, Issue:6

    Topics: Angioplasty, Balloon, Coronary; Animals; Butyrates; Cardiovascular Agents; Citrates; Coated Materials, Biocompatible; Coronary Angiography; Coronary Vessels; Equipment Design; Excipients; Female; Iohexol; Lecithins; Male; Models, Animal; Paclitaxel; Sus scrofa; Time Factors; Wound Healing

2011
Long-term clinical outcomes after treatment of stent restenosis with two drug-coated balloons.
    Coronary artery disease, 2018, Volume: 29, Issue:8

    Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Butyrates; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Equipment Design; Excipients; Female; Humans; Iohexol; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome

2018